The reliability, robustness and reproducibility of next-generation sequencing platforms are no longer questioned, making the unstoppable march of genomics into clinical practices a reality. However, many challenges remain for the successful translation of genomic knowledge into health advances and clinical utility.
Bio-IT World and Cambridge Healthtech Institute are again proud to host the Fourth Annual TCGC: The Clinical Genome Conference, inviting stakeholders impacting clinical genomics to share new findings and solutions for advancing the applications of clinical genome medicine.
Preliminary Agenda
Talk Title to be Announced
Nathaniel Pearson, Ph.D., Senior Director, Scientific Engagement & Public Outreach, New York Genome Center
Integrating the Principles of Preventative and Personalized Medicine to Advance Wellness
Nathan D. Price, Ph.D., Associate Director, Institute for Systems Biology
Impacting Healthcare with Data Analysis - Perspectives in Drug Discovery, Genomics and Wearables
Somalee Datta, Ph.D., Director, Bioinformatics, Stanford Center for Genomics & Personalized Medicine, Stanford University School of Medicine
Potential Clinical Genomics Applications in China
Bill Zheng, Ph.D., Director, Bioinformatics Section, Institute of Genetic Engineering, Southern Medical University
PatientsLikeMe: A Social Network and a Research Platform for Patient-Reported Data
Marcia M. Nizzari, MS, Vice President, Engineering, PatientsLikeMe, Inc.
Identification of Independent Primary Tumors and Intrapulmonary Metastases Using DNA Rearrangements in Non–Small Cell Lung Cancer
George Vasmatzis, Ph.D., Assistant Professor, Laboratory Medicine & Pathology, Mayo Clinic & Foundation
The Oncoscape Application in Cancer Big Data Analysis
Eric Holland, M.D., Ph.D., Director, Solid Tumor Translational Research, Fred Hutchinson Cancer Research Center
The Role of Genome Sequencing in Personalized Breast Cancer Prevention
Weiva Sieh, M.D., Ph.D., Assistant Professor, Epidemiolo gy, Department of Health Research and Policy, Stanford University School of Medicine
CIViC: Clinical Interpretation of Variants in Cancer
Malachi Griffith, Ph.D., Associate Director, The Genome Institute; Assistant Professor, Genetics, Washington University School of Medicine
Clinical Cost Effectiveness of Diagnostic Exome/Genome Sequencing
Stephen Kingsmore, D.Sc., Director, Center for Pediatric Genomic Medicine, Children’s Mercy Hospital
The Evaluation of the Patient Presenting with Symptoms of Obstructive Coronary Artery Disease: Clinical Validity, Clinical Utility and Economic Utility of a Blood-Based Test Incorporating Age, Sex and Gene Expression
Mark Monane, M.D., CMO, CardioDx
Myths and Realities of Clinical Genomics
David W. Moskowitz, M.D., Chairman, CEO, CMO & CSO, GenoMed, Inc.
An Approach to Whole-Genome Sequence as a Lifelong Health Resource
Sek Won Kong, M.D, Assistant Professor, Medicine/Informatics Program, Harvard Medical School and Boston Children’s Hospital
PANEL DISCUSSION: Reimbursement for Genomic Sequencing Services in a Time of Changing Healthcare Business Models
At a time when payers are asking themselves, "Why pay for sequencing services?", come meet the people who are successfully crafting reimbursement arguments for the payers in disease areas as diverse as inherited genetic diseases and oncology. Find out the tactics that are working and why.
Moderator: Katherine Tynan, Ph.D., Business Development & Strategic Consulting for Diagnostics Companies, Tynan Consulting LLC
Panelists to be Announced